The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study - Concepedia

Concepedia

Publication | Open Access

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

DOI Full Paper Access

55

Citations

41

References

2010

Year

E. Jane Macaskill, John M.S. Bartlett, Vicky S. Sabine, Dana Faratian, Lorna Renshaw, Stephen L. White, Fiona Campbell, O. Young, Linda Williams, Jeremy Thomas,

Breast Cancer Research and Treatment

Mammalian TargetRapamycin Inhibitor EverolimusBreast OncologyEarly Breast CancerMedicinePathologyBreast CancerAnti-cancer AgentCell BiologyCancer TreatmentOncologyRadiation OncologyEndocrine-related Cancer

References

	Year	Citations

Page 1

Page 1